Specify a stock or a cryptocurrency in the search bar to get a summary
Fluicell AB
5J9Fluicell AB (publ) operates as a life science company, provides platforms and research solutions for bioprinting and single-cell biology. The company offers BIOPEN, a microfluidic platform for high-precision single-cell solution delivery that enables to control the cell microenvironment without moving or disturbing the cells; Biozone 6 that generate dose-response curves or study the effects of multiple drug compounds; and Dynaflow Resolve system, an ion channel screening platform, which allows to record various ion channel current in patch-clamp recording configuration. It also provides Biopixlar, a 3D single-cell bioprinting platform that enables high cell viability and cell-to-cell communication; and Biopixlar AER, an easy-to-use 3D bioprinting platform that fits into your fume hood or biosafety cabinet. The company also offers accessory and consumable products for bioprinting and single-cell biology. The company was incorporated in 2012 and is based in Mölndal, Sweden. Address: Flöjelbergsgatan 8C, Mölndal, Sweden, 431 37
Analytics
WallStreet Target Price
–P/E ratio
0.359Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures 5J9
Dividend Analytics 5J9
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History 5J9
Stock Valuation 5J9
Financials 5J9
Results | 2019 | Dynamics |